european psychiatric association

Neurodevelopmental Disorders Across the Lifespan (NDAL)

Section committee

RAMOS-QUIROGA Josep Antoni , Chair

ASHERSON Philip, Co-Chair

SOBANSKI Esther, Secretary


Aims & Objectives

Section mission

Neurodevelopmental disorders, like attention deficit hyperactivity disorder and autism spectrum disorders are impairments of the growth and development of the brain. These conditions typically have a childhood onset and persist into adult life, but there is a significant unmet clinical and research need to understand the persistence into adulthood. Neurodevelopmental disorders are associated with a significant mental, physical, and economic consequences for individuals, and in turn their families and society in general. 

The mission of the Section is to promote the improvement of mental health services to patients with neurodevelopmental disorders across lifespan via the creation of a forum in which research, training, diagnosis, and treatment can be explored in a specifically European context.

Aims

  1. To promote the training in neurodevelopmental disorders across lifespan.
  2. To enhance the knowledge about the persistence of neurodevelopmental disorders across lifespan.
  3. To improve diagnosis and treatment of neurodevelopmental disorders in adulthood.
  4. To promote research in neurodevelopmental disorders across life span in Europe.

Objectives

  1. To organize scientific and educational symposia during the annual European Congress of Psychiatry.
  2. To organize a Continuing Medical Education (CME) course on neurodevelopmental disorders across lifespan in collaboration with national psychiatry societies.
  3. Collaboration with other EPA sections.
  4. Collaboration with the WPA and ECNP in order to improve the management and the research of these disorders across life span.
  5. Networking with other European organizations, with a focus on neurodevelopmental disorders, such as the European Network of Adult ADHD or Family Caretakers Associations.
  6. To establish a platform for the creation of consortiums to increase the research in this field in Europe. 

Section's activities

1. Section symposium at EPA annual meeting.

2. Workshops at EPA congresses.

3. Educational materials about neurodevelopmental disorders across lifespan.

4. Publications (guidelines, results of collaborative research, etc…).

5. Strengthening collaboration between European psychiatrist in the field of research, knowledge transfer and exchange in the field of neurodevelopmental disorders across the lifespan. 

Section objectives

  1. To promote the training in neurodevelopmental disorders across lifespan.

Activities

Meetings/events

Annual Meeting of the NDAL Section.

Annual Meeting of the NDAL Section.
Description :

The Section “Neurodevelopmental disorders across lifespan” (NDAL) has organized a business meeting per year since the approval of the Section. NDAL was promoted by a group of 15 psychiatrists interested in this field. The Section is now composed by 30 professionals. The elections of Chair (Prof. J. Antoni Ramos-Quiroga), co-Chair (Prof. Philip Asherson) and Secretary (Prof. Esther Sobanski) has been made as required.

Objectives:  To organize the annual official meeting of the NDAL section. The chair, co-chair and secretary was renovated as mandatory. For the next 2 years the board will heave the same composition as the latest board: 

 

Chair: Prof. J. Antoni Ramos-Quiroga

Vice-Chair: Prof. Philip Asherson 

Secretary: Prof. Esther Sobanski 

 

During the meeting, we approved the new version of the European Consensus on Adult ADHD. The manuscript was published at the end of 2018:

Kooij JJS, Bijlenga D, Salerno L, Jaeschke R, Bitter I, Balázs J, Thome J, Dom G, Kasper S, Nunes Filipe C, Stes S, Mohr P, Leppämäki S, Casas Brugué M, Bobes J, Mccarthy JM, Richarte V, Kjems Philipsen A, Pehlivanidis A, Niemela A, Styr B, Semerci B, Bolea-Alamanac B, Edvinsson D, Baeyens D, Wynchank D, Sobanski E, Philipsen A, McNicholas F, Caci H, Mihailescu I, Manor I, Dobrescu I, Saito T, Krause J, Fayyad J, Ramos-Quiroga JA, Foeken K, Rad F, Adamou M, Ohlmeier M, Fitzgerald M, Gill M, Lensing M, Motavalli Mukaddes N, Brudkiewicz P, Gustafsson P, Tani P, Oswald P, Carpentier PJ, De Rossi P, Delorme R, Markovska Simoska S, Pallanti S, Young S, Bejerot S, Lehtonen T, Kustow J, Müller-Sedgwick U, Hirvikoski T, Pironti V, Ginsberg Y, Félegyházy Z, Garcia-Portilla MP, Asherson P. Updated European Consensus Statement on diagnosis and treatment of adult ADHD. Eur Psychiatry. 2018 Nov 16;56:14-34. doi: 10.1016/j.eurpsy.2018.11.001. [Epub ahead of print] PubMed PMID: 30453134.

Also, were approved objectives of the Section and future activities. 

Venue :
26th European Congress of Psychiatry. Nice
Date :
March 5th 2018

Symposium: “Attention-deficit hyperactivity disorder and suicide?”

Symposium: “Attention-deficit hyperactivity disorder and suicide?”
Description :

NDAL Section organized an official symposium during the 26th European Congress of Psychiatry in Nice, 2018 (March 5th). It was jointed with Suicidology and Suicide Prevention section.

 

“Attention-deficit hyperactivity disorder and suicide?”

 

Chairs: Judit Balazs, Philip Asherson

Speakers:

  • Aetiological links between ADHD and the development of depression

Philip Asherson

  • Prevalence and treatment of ADHD and mood disorders

Sandra Kooij

  • Possible association between attention deficit hyperactivity disorder and attempted suicide in adolescents

Zalsman G and Manor I, Gutnik I, Ben-Dor, DH, Apter A, Sever J, Tyano S, Weizman A

  • ADHD and Suicide and Non-Suicidal Self Injury: the role of comorbidity

Judit Balazs

Venue :
26th European Congress of Psychiatry in Nice
Date :
5 March 2018

EPA Academia Educational Course

EPA Academia Educational Course
Description :

NDAL Section has organized an EPA Academia Educational Course entitled “Attention-deficit/hyperactivity disorder (ADHD) in adults: nosology, diagnostic process and treatment” during the 26th European Congress of Psychiatry in Nice (Mach 3th 14:45-18:15).

 

Chair: Esther Sobanski

 

  • Background data, epidemiology, etiology, pathophysiology

Philip Asherson, London, United Kingdom

  • Clinical picture

Sandra Kooij, The Hague, Netherlands

  • Pharmacotherapy

J. Antoni Ramos-Quiroga, Barcelona, Spain

  • Psychotherapy

Esther Sobanski, Mannheim, Germany

Venue :
26th European Congress of Psychiatry in Nice
Date :
3 March 2018

Publications

Updated European Consensus Statement on diagnosis and treatment of adult ADHD.

Updated European Consensus Statement on diagnosis and treatment of adult ADHD.
Journal :
Eur Psychiatry. 2018 Nov 16;56:14-34.
Journal :
Kooij JJS, Bijlenga D, Salerno L, Jaeschke R, Bitter I, Balázs J, Thome J, DomG, Kasper S, Nunes Filipe C, Stes S, Mohr P, Leppämäki S, Casas Brugué M, BobesJ, Mccarthy JM, Richarte V, Kjems Philipsen A, Pehlivanidis A, Niemela A, Styr B,Semerci B, Bolea-Alamanac B, Edvinsson D, Baeyens D, Wynchank D, Sobanski E,Philipsen A, McNicholas F, Caci H, Mihailescu I, Manor I, Dobrescu I, Saito T,Krause J, Fayyad J, Ramos-Quiroga JA, Foeken K, Rad F, Adamou M, Ohlmeier M,Fitzgerald M, Gill M, Lensing M, Motavalli Mukaddes N, Brudkiewicz P, Gustafsson P, Tani P, Oswald P, Carpentier PJ, De Rossi P, Delorme R, Markovska Simoska S,Pallanti S, Young S, Bejerot S, Lehtonen T, Kustow J, Müller-Sedgwick U,Hirvikoski T, Pironti V, Ginsberg Y, Félegyházy Z, Garcia-Portilla MP, AshersonP.
Acknowledged as official Section publication ? Yes